Arsenic and blood lactate dehydrogenase increased Patient Reports February 12, 2012

Arsenic Side Effects Report #5926589-9
Arsenic side effect was reported by a Health Professional from ITALY on Oct 01, 2008. Male patient, 75 years of age, weighting 185.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, blood lactate dehydrogenase increased, cardiac failure, electrocardiogram repolarisation abnormality, hypoxia, pco2 decreased, platelet count decreased, sinus tachycardia. Arsenic dosage: 25.2 MG CYCLE 1 INTRAVENOUS DRIP. During the same period patient was treated with CLORFENAMINA MALEATO, IRBESARTAN, METFORMIN HYDROCHLORIDE, LENOGASTRIM, ASCORBIC ACID, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #5853385-3
Arsenic side effect was reported by a Physician from ITALY on Jan 23, 2008. Male patient, 74 years of age, weighting 185.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, blood lactate dehydrogenase increased, cardiac failure, dyspnoea, pco2 decreased, platelet count decreased, po2 decreased. Arsenic dosage: 25.2 MG CYCLE 1 INTRAVENOUS DRIP. During the same period patient was treated with CLORFENAMINA MALEATO, IRBESARTAN, METFORMIN, LENOGASTRIM. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #5919004-2
Arsenic side effect was reported by a Physician from ITALY on Oct 01, 2008. Male patient, 74 years of age, weighting 185.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood lactate dehydrogenase increased, cardiac failure, dyspnoea, electrocardiogram repolarisation abnormality, hypoxia, sinus tachycardia. Arsenic dosage: 25.2 MG CYCLE 1 INTRAVENOUS DRIP. During the same period patient was treated with CLORFENAMINA MALEATO, IRBESARTAN, METFORMIN, LENOGRASTIM, ASCORBIC ACID, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #5994520-6
Arsenic side effect was reported by a Physician from ITALY on Dec 04, 2008. Male patient, 74 years of age, weighting 185.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, blood lactate dehydrogenase increased, cardiac failure, dyspnoea, pco2 decreased, platelet count decreased, po2 decreased, sinus tachycardia. Arsenic dosage: 25.2 MG CYCLE 1 INTRAVENOUS DRIP. During the same period patient was treated with CLORFENAMINA MALEATO, IRBESARTAN, METFORMIN, LENOGRASTIM, ASCORBIC ACID, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.


Arsenic Side Effects Report #5081598-X
Arsenic side effect was reported by a Physician from JAPAN on July 27, 2006. Female patient, 76 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood fibrinogen increased, blood lactate dehydrogenase increased, fibrin d dimer increased, gamma-glutamyltransferase increased. Arsenic dosage: 9.285 MG QD INTRAVENOUS DRIP. During the same period patient was treated with CEFPIROME SULPHATE, MICAFUNGIN, ACYCLOVIR. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #4983246-3
Arsenic side effect was reported by a Physician from JAPAN on Apr 05, 2006. Male patient, 63 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, blood lactate dehydrogenase increased, cardio-respiratory arrest, cerebral haemorrhage, chest x-ray abnormal, disseminated intravascular coagulation, dyspnoea exertional, leukocytosis, loss of consciousness. Arsenic dosage: 7.2 MG QD INTRAVENOUS DRIP. During the same period patient was treated with DALTEPARIN. Patient was hospitalized. Patient died on 01/11/2006.